Skip to main content
. 2021 Mar 2;48(10):3277–3285. doi: 10.1007/s00259-021-05271-w

Fig. 1.

Fig. 1

MIP of patient #8 (male 63 years. Mass dose of 10 mg girentuximab) demonstrating a ccRCC tumour in left kidney (red arrow) at 0.5 h p.a. with an increased tumour to background ratio over time. MIP, maximum intensity projection